Using T cells to target malignant brain tumors
Doctors and scientists from the German Cancer Research Center (DKFZ) and from Heidelberg University’s Medical Faculty Mannheim have successfully tested a neoantigen-specific transgenic immune cell therapy for malignant brain tumors for the first time using an experimental model in mice. Cellular immunotherapies that specifically target malignant tumors are thought to be a promising approach in […]